Clinical experience with ranolazine in a veteran population with chronic stable angina.

about

Osteoporosis Preventive Practice Between Veteran and Nonveteran Older Adults: Findings From Patient-Reported Data Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.

P2860

Q31142571-712A8290-6ECB-447A-8CE1-FEB721021DAD Q37199774-A3627C30-0057-421A-90E1-045768B93ECE

P2860

Clinical experience with ranolazine in a veteran population with chronic stable angina.

Item

http://www.wikidata.org/entity/Q45330316

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@en

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@nl

type

Item

label

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@en

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@nl

prefLabel

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@en

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@nl

P1476

Clinical experience with ranolazine in a veteran population with chronic stable angina.

@en

P2093

Andrew J Franck

http://www.w3.org/2001/XMLSchema#string

David J Frohnapple

http://www.w3.org/2001/XMLSchema#string

Don N Reeder

http://www.w3.org/2001/XMLSchema#string

Michael A Gillette

http://www.w3.org/2001/XMLSchema#string

P2860

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Universal definition of myocardial infarction.

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.

Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.

P304

42-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1Q487

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22215689

http://www.w3.org/2001/XMLSchema#string

P921

veteran

Clinical experience with ranolazine in a veteran population with chronic stable angina.

about

P2860

P2860

Clinical experience with ranolazine in a veteran population with chronic stable angina.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921